BPR-35000858
/ Chengdu Brilliant Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 22, 2026
BPR-35000858, an ALK7-Targeting SiRNA, Demonstrates Potent Adiposity Reduction and a Favorable Safety Profile in Preclinical Mouse and Nonhuman Primate Models
(OBESITY WEEK 2026)
- No abstract available
Preclinical • Obesity
1 to 1
Of
1
Go to page
1